• News (4)
    bbc.co.uk (08 May 2018)

    Takeda agrees to buy Shire in £46bn deal

    SHIRE PHARMACEUTICALS has been acquired by Japan's Takeda for £46bn, subject to approval by shareholders. The bid was finally successfully following five different offers being made since late March. Takeda hopes the deal will strengthen its cancer, stomach and brain drug offerings. 

    Read Full Article

    Marketing Week (01 Mar 2007)

    SHIRE PHARMACEUTICALS has launched a new website called dementialink.co.uk to promote its Alzheimer's drug Reminyl XL. The Alzheimer's Society has criticised the company for launching the site during Alzheimer's Awareness week.